-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Marinus Pharmaceuticals, Inc. quarterly/annual Revenues history and growth rate from Q3 2020 to Q2 2024.
- Marinus Pharmaceuticals, Inc. Revenues for the quarter ending June 30, 2024 was $8.06M, a 32.5% increase year-over-year.
- Marinus Pharmaceuticals, Inc. Revenues for the twelve months ending June 30, 2024 was $30.3M, a 16.6% increase year-over-year.
- Marinus Pharmaceuticals, Inc. annual Revenues for 2023 was $31M, a 21.6% increase from 2022.
- Marinus Pharmaceuticals, Inc. annual Revenues for 2022 was $25.5M, a 66% increase from 2021.
- Marinus Pharmaceuticals, Inc. annual Revenues for 2021 was $15.3M, a 793% increase from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)